SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial

Sclerostin is an osteocyte-produced glycoprotein that inhibits the WNT/β-catenin pathway essential for bone formation. Sclerostin was postulated to relate to normal bone metabolism in 2001; we still have an incomplete understanding of its regulation. Estradiol, a bone antiresorptive ovarian steroid,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Yang, Yuebo, Goshtasebi, Azita, van Lierop, Antoon, Kalidasan, Dharani, Prior, Jerilynn
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2019
Assuntos:
Bone and Mineral Metabolism
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553262/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares